查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728386

醫療保健市場中的冷等離子體—全球產業規模、佔有率、趨勢、機會和預測，按應用（傷口癒合、外科應用和其他醫療應用）細分，按地區和競爭情況，2020 年至 2030 年預測

Cold Plasma in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Wound Healing, Surgical Application and Other Medical Applications), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球醫療保健冷等離子市場價值為 21.4 億美元，預計到 2030 年將達到 42.5 億美元，預測期內複合年成長率為 12.11%。冷等離子體是一種非熱、非侵入性電離氣體技術，它透過其廣泛的應用，包括傷口癒合、消毒、癌症治療和皮膚病治療，正在改變現代醫療保健。它能夠消滅病原體、促進組織再生、刺激血管生成，而不會損害健康組織，使其成為有價值的醫療工具。

市場概覽
預測期 2026-2030
2024年市場規模 21.4億美元
2030年市場規模 42.5億美元
2025-2030 年複合年成長率 12.11%
成長最快的領域 傷口癒合
最大的市場 北美洲

隨著全球慢性病盛行率的上升，特別是糖尿病和癌症等需要先進的微創治療的疾病，市場正在獲得發展動力。冷等離子體在治療慢性傷口和輔助控制感染方面顯示出良好的效果，這在疫情後的醫療保健策略中尤其重要。此外，學術和臨床研究強調冷等離子體幾乎立即去活化空氣傳播病毒的潛力，人們對呼吸治療應用的興趣激增。這些發展凸顯了冷等離子體技術作為一種可靠、創新的治療和消毒解決方案在各種醫療環境中的應用日益廣泛。

關鍵市場促進因素

慢性病增多

主要市場挑戰

融入醫療保健工作流程

主要市場趨勢

數據驅動的醫療保健

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球醫療保健冷等離子市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按應用（傷口癒合、外科手術和其他醫療應用）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美醫療保健冷等離子市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫療保健冷等離子體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太地區醫療保健冷等離子體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲醫療保健冷等離子體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲醫療保健市場冷等離子展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購

第 13 章：醫療保健市場中的全球冷等離子：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代治療類型的威脅

第 15 章：競爭格局

  • Neoplas med GmbH
  • US Medical Innovations
  • Terumo Medical Corp
  • Adtec Plasma Technology Co Ltd
  • Apyx Medical Corp
  • Nordson Corp
  • Europlasma NV
  • Terraplasma GmbH
  • Henniker Plasma
  • Smith & Nephew plc

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16339

The Global Cold Plasma in Healthcare Market was valued at USD 2.14 Billion in 2024 and is projected to reach USD 4.25 Billion by 2030, growing at a CAGR of 12.11% during the forecast period. Cold plasma, a non-thermal, non-invasive ionized gas technology, is transforming modern healthcare with its wide range of applications, including wound healing, sterilization, cancer therapy, and dermatological treatments. Its ability to destroy pathogens, promote tissue regeneration, and stimulate angiogenesis without damaging healthy tissue makes it a valuable medical tool.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.14 Billion
Market Size 2030USD 4.25 Billion
CAGR 2025-203012.11%
Fastest Growing SegmentWound Healing
Largest MarketNorth America

The market is gaining momentum as chronic disease prevalence rises globally, particularly in conditions like diabetes and cancer that require advanced, minimally invasive treatments. Cold plasma is showing promising results in managing chronic wounds and aiding infection control-especially crucial in post-pandemic healthcare strategies. Additionally, with academic and clinical research highlighting cold plasma's potential to inactivate airborne viruses almost instantly, interest has surged for respiratory therapy applications. These developments underscore the increasing adoption of cold plasma technology as a reliable, innovative therapeutic and sterilization solution across diverse medical settings.

Key Market Drivers

Increasing Chronic Diseases

The growing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a major factor driving demand for cold plasma technologies in healthcare. According to the World Health Organization, noncommunicable diseases (NCDs) accounted for over 43 million deaths in 2021, with a disproportionate impact in low- and middle-income countries.

Cold plasma has emerged as a promising treatment modality for addressing the complications arising from these conditions. For instance, in diabetic patients, chronic ulcers present a persistent challenge; cold plasma accelerates healing by enhancing tissue oxygenation and reducing microbial load. Similarly, its application in oncology helps target cancer cells while sparing healthy tissue, offering an advanced alternative to traditional therapies. As healthcare systems globally aim to manage rising NCDs with precision and minimal side effects, the role of cold plasma technologies is becoming increasingly significant.

Key Market Challenges

Integration into Healthcare Workflows

One of the critical challenges in the cold plasma healthcare market is integrating these advanced technologies into established clinical workflows. Many healthcare facilities operate within strict procedural frameworks and require seamless compatibility with existing medical infrastructure.

Adopting cold plasma devices involves not only purchasing equipment but also modifying infrastructure, allocating physical space, and ensuring adequate training for clinical staff. These adjustments may be resource-intensive and time-consuming, particularly in smaller hospitals or facilities in developing regions. Without smooth integration, the potential clinical benefits of cold plasma may be underutilized or delayed, hampering market expansion despite the technology's efficacy.

Key Market Trends

Data-Driven Healthcare

The shift toward data-driven healthcare is reshaping how cold plasma devices are utilized. The integration of smart sensors and real-time monitoring capabilities allows healthcare providers to collect treatment data-such as gas flow, temperature, and dosage metrics-during procedures.

These insights enhance treatment precision and improve outcomes. For instance, in wound care, real-time feedback helps clinicians adjust parameters on-the-fly to accelerate healing. In oncology, data analytics can optimize dosage delivery to ensure cancer cells are effectively targeted. The ability to personalize treatment protocols based on real-time patient data marks a critical step in aligning cold plasma technology with the broader movement toward precision medicine and connected healthcare systems.

Key Market Players

  • Neoplas med GmbH
  • U.S. Medical Innovations
  • Terumo Medical Corp
  • Adtec Plasma Technology Co Ltd
  • Apyx Medical Corp
  • Nordson Corp
  • Europlasma NV
  • Terraplasma GmbH
  • Henniker Plasma
  • Smith & Nephew plc

Report Scope:

In this report, the Cold Plasma in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cold Plasma in Healthcare Market, By Application:

  • Wound Healing
  • Surgical Application
  • Other Medical Applications

Cold Plasma in Healthcare Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cold Plasma in Healthcare Market.

Available Customizations:

Cold Plasma in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cold Plasma in Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Wound Healing, Surgical Application and Other Medical Applications)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Cold Plasma in Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cold Plasma in Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
    • 6.3.2. Canada Cold Plasma in Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
    • 6.3.3. Mexico Cold Plasma in Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application

7. Europe Cold Plasma in Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cold Plasma in Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
    • 7.3.2. United Kingdom Cold Plasma in Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
    • 7.3.3. Italy Cold Plasma in Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Application
    • 7.3.4. France Cold Plasma in Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
    • 7.3.5. Spain Cold Plasma in Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application

8. Asia-Pacific Cold Plasma in Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cold Plasma in Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
    • 8.3.2. India Cold Plasma in Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
    • 8.3.3. Japan Cold Plasma in Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
    • 8.3.4. South Korea Cold Plasma in Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
    • 8.3.5. Australia Cold Plasma in Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application

9. South America Cold Plasma in Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cold Plasma in Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
    • 9.3.2. Argentina Cold Plasma in Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
    • 9.3.3. Colombia Cold Plasma in Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application

10. Middle East and Africa Cold Plasma in Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cold Plasma in Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
    • 10.3.2. Saudi Arabia Cold Plasma in Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
    • 10.3.3. UAE Cold Plasma in Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions

13. Global Cold Plasma in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

  • 15.1. Neoplas med GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Product & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. U.S. Medical Innovations
  • 15.3. Terumo Medical Corp
  • 15.4. Adtec Plasma Technology Co Ltd
  • 15.5. Apyx Medical Corp
  • 15.6. Nordson Corp
  • 15.7. Europlasma NV
  • 15.8. Terraplasma GmbH
  • 15.9. Henniker Plasma
  • 15.10. Smith & Nephew plc

16. Strategic Recommendations

17. About Us & Disclaimer